CHRW delivered another quarter of double-digit earnings growth, reinforcing its ability to execute on its Lean AI strategy. The strong results provide a positive backdrop for the pending RXO acquisition, as management directly linked the operating model to integration success. Monitor the S-4 registration statement filing and any regulatory updates for the deal timeline.
How the stock moved after the report
⚠ Clustered BULLISH VIEWSTOCK BELOW ENTRY AT T+1- T+0 · Oct 28 $27.65entry
- T+1 · 6d ago −0.58%α +1.19% · $27.49
- T+5 · due 7h ago Pending
- T+5 · todayOpen
- T+20 · in 21d Pending
- T+60 · in 3mo Pending
Price Chart
How similar events traded
Executive Summary
C.H. Robinson (CHRW) filed its Q3 2026 earnings results, reporting strong double-digit growth in revenue, income from operations, and EPS. The filing also serves as a Rule 425 communication regarding the pending $5.8 billion acquisition of RXO, with management emphasizing that the same operating model driving CHRW's results will enable successful integration of RXO. No changes to deal terms or timeline were disclosed.
Key Financial Metrics
Key Facts
- Total revenues increased 29.5% to $5.4 billion in Q3 2026 vs Q3 2025
- Income from operations increased 23.1% to $271.8 million
- Diluted EPS increased 24.6% to $1.67; adjusted diluted EPS increased 28.6% to $1.80
- NAST volume increased ~3.5% YoY, outpacing the Cass Freight Shipment Index for the 14th consecutive quarter
- NAST and Global Forwarding both achieved mid-cycle operating margin targets
- Cash returned to shareholders increased 52.5% to $289.1 million, including $214.3 million in share repurchases
- Cash generated from operations decreased to $124.1 million from $275.4 million due to working capital changes
- Pending $5.8 billion acquisition of RXO by CHRW expected to close in H1 2027, with no term changes disclosed
Financial Impact
Revenue +29.5%, operating income +23.1%, diluted EPS +24.6% YoY in Q3 2026
Risk Factors
- Cash from operations declined significantly due to working capital tied to higher transportation rates
- Pending RXO acquisition faces regulatory and stockholder approval risks, with a $175M termination fee
- Integration of RXO may be more costly or take longer than anticipated
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 425 Filing (Primary) | 0001193125-26-436303 |
| Document: 0001193125-26-436303-index-headers.html | 0001193125-26-436303 |
| Document: 0001193125-26-436303-index.html | 0001193125-26-436303 |
| Document: 0001193125-26-436303.txt | 0001193125-26-436303 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 30, 2026 4d ago | 425 | $27.82 | awaiting T+5 | awaiting T+5 | $28.24 (+1.51%) |
Oct 29, 2026 5d ago | 425 | $27.49 | awaiting T+5 | awaiting T+5 | $28.24 (+2.73%) |
Oct 29, 2026 6d ago | 8-K | $27.65 | awaiting T+5 | awaiting T+5 | $28.24 (+2.13%) |
Oct 28, 2026 6d ago | 425 | $27.65 | awaiting T+5 | awaiting T+5 | $28.24 (+2.13%) |
Oct 28, 2026 6d ago | 425 | $27.65 | awaiting T+5 | awaiting T+5 | $28.24 (+2.13%) |
Oct 28, 2026 6d ago | 425 | $27.65 | awaiting T+5 | awaiting T+5 | $28.24 (+2.13%) |
Oct 9, 2026 26d ago | 425 | $29.08 $28.60 | ▼ −1.65% | ▲ +0.32% | $28.24 (−2.89%) |
Oct 8, 2026 26d ago | 425 | $29.08 $28.60 | ▼ −1.65% | ▲ +0.32% | $28.24 (−2.89%) |
Oct 6, 2026 28d ago | 425 | $28.36 $28.69 | ▲ +1.16% | ▲ +2.14% | $28.24 (−0.42%) |
Oct 6, 2026 28d ago | 425 | $28.36 $28.69 | ▲ +1.16% | ▲ +2.14% | $28.24 (−0.42%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers